期刊文献+

凋亡相关蛋白Bcl-XL和Bak在口腔黏膜癌前病变和鳞癌组织中的表达 被引量:2

Expression of Apoptosis-related Proteins Bcl-XL and Bak in Premalignant and Mali gnant Lesions of the Oral Epithelium.
下载PDF
导出
摘要 目的 :探讨凋亡相关蛋白Bcl-XL和Bak在口腔鳞状细胞癌组织发生、发展过程中的表达及意义。方法 :采用免疫组织化学SP法检测 8例正常口腔黏膜上皮、7例异常增生上皮和 4 2例鳞癌组织中Bcl-XL和Bak的表达。结果 :Bcl-XL和Bak在正常黏膜上皮中的表达分别有 12 .5 0 % (1/ 8)阳性率 ;Bcl -XL在鳞癌组织中的表达高于其在正常黏膜与异常增生上皮中的表达 (P <0 .0 5 ) ,差异有显著性 ;Bak在异常增生上皮和鳞癌组织中的表达明显高于正常黏膜 (P <0 .0 5 ) ,但在低分化鳞癌组的表达较高分化组明显降低 (P <0 .0 5 )。结论 :抑凋亡蛋白Bcl-XL上调导致异常增生上皮或 (和 )癌细胞积累。促凋亡因子Bak在代偿性过表达后 ,其作用随癌组织分化程度降低而减弱 ,癌细胞凋亡受限 ,恶性度增强。细胞凋亡的异常调控对口腔鳞癌的发生。 Objective:To investigate the expression and significanc e of apoptosis-related proteins Bcl-XL and Bak during the development and progress ion of oral squamous cell carcinoma(SCC).Methods:8 normal oral epithelia,7 dysplasia epithelia and 42 SCCs were evaluated in immunohistoch emically stained sections for apoptosis regulatory proteins Bcl-XL and Bak.Results:In normal epithelia, the positive rates of Bcl-XL and B ak were both 12.50%(1/8). In SCCs, the positive rate of Bcl-XL was significantly higher than in normal and dysplasia epithelia ( P <0.05).The positive rate of Bak increased significantly in dysplasia epithelia and SCCs (compared with norm al epithelia, P <0.05), and the positive intensity in poorly differentiated SC Cs was lower than in well differentiated SCCs( P <0.05).Conclusions :Up-expression of apoptosis suppressor protein Bcl-XL results in accu mulation of dysplasia and carcinoma cells.Apoptosis is controled due to a decrea se in expression of apoptosis promoter protein Bak after its compensational over -expression.The cooperation of Bcl-XL and Bak results in the progression of SCC. Deregulation of apoptosis could be important to oral carcinogenesis.
出处 《口腔医学研究》 CAS CSCD 2003年第5期362-364,共3页 Journal of Oral Science Research
关键词 凋亡相关蛋白 Bcl—XL BAK 口腔黏膜 癌前病变 鳞癌组织 表达 细胞凋亡 Carcinoma Squamous cell Apoptosis Bcl-XL Bak
  • 相关文献

参考文献9

  • 1Gatalica Z, Lele SM, Rampy BA, et al. The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma. Cancer,2000,88: 1 378 - 1 383.
  • 2Pena JC,Thompson CB, Recant W, et al. Bcl -XL and Bcl -2 expression in squamous cell carcinoma of the head and neck.Cancer,1999,85: 164 - 170.
  • 3Noutomi T,Chiba H,Itoh M,et al. Bcl - x(L) coders multi -drug resistance in several squamous cell carcinoma cell lines. Oral Oncol,2002,38 ( 1 ) : 41 - 48.
  • 4Piattelli A, Rubini C, Fioroni M, et al. Prevalance of p53, bcl - 2,and Ki -67 immunoreactivity and Apoptosis in Normal Oral Epithelium and in Premalignant and Malignant Lesions of the Oral Cavity. Oral Maxillofac Surg,2002,60: 532 -540.
  • 5Veltri RR, Vukanovic J, Epstein JJ, et al. Implication of cell kinetic changes during the progression of human prostatic cancer.CLin Cancer Res, 1995,1 ( 1 ) : 473 -480.
  • 6Krajewski S, Krajewska M, Reed JC, et al.Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptosis member of the Bcl - 2 protein family. Cancer Research, 1996,56: 5501-5507.
  • 7Macluskey M, Chandrachud LM, Pazouki S, et al. Apoptosis, proliferation, and angiogenesis in oral tissues. Possible revelance to tumour progression. J Pathol,2000,191 : 368 - 375.
  • 8M Zornig, A O Hueber, W. Banm, et al. Apoptosis regulators and their role in tumorigenesis. Biochimica et Biophysica Actu 2001,1551:F1-F37.
  • 9Cheng EH - YA, Wei MC, Weiler S, et al. Bcl - 2, Bcl - XL sequester BH3 domain - only molecules preventing BAX - and BAK - mediated mitochondrial apoptosis. Mol Cell ,2001,8: 705-711.

同被引文献20

  • 1Krajewski S,Krajewska M,Shabaik A,et al.Immunohistochemical determination of in vivo distribution of Bax adominant inbitor of BCL-2[J].Am J Pathol,1994,145:1323-1336
  • 2Gonzalez-Garcia M,Perez-Ballestero R,Ding L,et al.Bcl-XL is the major Bcl-X mRNA form expressed during murine development and its product localizes to mitochondria[J].Development,1994,120(10):3033-3042
  • 3Park JR,Bernstein ID,Hockenbery DM.Primitive human hematopoietic precursors express Bcl-X but not Bcl-2[J].Blood,1995,86(3):868-876
  • 4Yin C,Knudoson CM,Korsmeyer SJ,et al.Bax suppresses of Tumourigenesis and stimulates apoptosis in vivo[J].Nature,1997,385(6617):637
  • 5Yang E,Zha J,Jockei J,et al.Bad,a heterodimeric partner for Bcl-XL and Bcl-2,displaces Bax and promotes cell death[J].Cell,1995,80(2):285-291
  • 6Kharbanda S,Pandey P,Schofield L,et al.Role for Bcl-XL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis[J].Proc Natl Acad Sci USA.1997,94(13):6939-6942
  • 7Schott AF,Apel IJ,Nunez G,et al.Bcl-XL protects cancer cells from p53-mediated apoptosis[J].Oncogene,1995,11(7):1389-1394
  • 8Erlacher L,Maier R,Ullrich R,et a1.Differential expression of the protooncogene Bcl-2 in mormal and osteoarthritic human articular cartelage[J].J Rheumatol,1995,22:926-931
  • 9Krasmeyer SJ,Shutter JR,Veis DJ,et al.Bcl-2/Bax a rheostat that regulates an anti-oxidant pathway and cell[J].Semin Cancer Bilo,1993,4:327
  • 10Yin C,Knudoson CM,Korsmeyer SJ,et a1.Bax suppresses of tumourigenesis and stimulates apoptosis in vivo[J].Nature,1997,385(6617):637

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部